367
Participants
Start Date
May 1, 2023
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
chemotherapy plus TCM 1&ICIs plusTCM2 placebo
"In China,TCM herbs are given on the basis of the TCM syndrome differentiation as diagnosed by the TCM herbal specialist. Prescriptions formulated into granules origin from Professor Liu Jia-xiang and Xu Ling. Package of granules is made into two types with functions such as tonifying the stomach and nourishing the blood recipe, benefiting Qi Yin and detoxification and resolving masses recipe. The herbal treatment is adapted to the syndromes.~Chemotherapy:Vincristine/paclitaxel/docetaxel/pemetrexed/gemcitabine plus cisplatin/carboplatin:administrated for patients with NSCLC requiring post-operative adjuvant therapy.~ICIs:Nivolumab/Pembrolizumab/Durvalumab/Atezolizumab/ Camrelizumab/Dupilumab/Sintilimab/Tislelizumab:administrated for patients with NSCLC requiring post-operative adjuvant therapy."
chemotherapy plus TCM 1placebo &ICIs plus TCM2 placebo
"Chemotherapy:Vincristine/paclitaxel/docetaxel/pemetrexed/gemcitabine plus cisplatin/carboplatin:administrated for patients with NSCLC requiring post-operative adjuvant therapy.~ICIs:Nivolumab/Pembrolizumab/Durvalumab/Atezolizumab/ Camrelizumab/Dupilumab/Sintilimab/Tislelizumab:administrated for patients with NSCLC requiring post-operative adjuvant therapy."
YueYang Hosptial of Intergrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine, Shanghai
Shanghai Pulmonary Hospital, Shanghai, China
OTHER
Shanghai Chest Hospital
OTHER
Fudan University
OTHER
Shanghai Zhongshan Hospital
OTHER
Ruijin Hospital
OTHER
Shanghai University of Traditional Chinese Medicine
OTHER